SeaSpine（纳斯达克股票代码：SPNE）在StockNews.com上升级

StockNews.com upgraded shares of SeaSpine (NASDAQ:SPNE – Get Rating) from a sell rating to a hold rating in a research note issued to investors on Friday morning.

A number of other equities research analysts have also commented on SPNE. Cantor Fitzgerald dropped their price objective on shares of SeaSpine from $27.00 to $21.00 and set an overweight rating on the stock in a report on Friday, April 22nd. BTIG Research dropped their price objective on shares of SeaSpine from $23.00 to $19.00 in a report on Thursday, June 30th. One research analyst has rated the stock with a hold rating and six have given a buy rating to the company. According to MarketBeat.com, SeaSpine has an average rating of Moderate Buy and an average price target of $32.83.

Get SeaSpine alerts:

SeaSpine Stock Performance

SPNE opened at $5.95 on Friday. The firm's fifty day moving average is $7.25 and its two-hundred day moving average is $10.19. The firm has a market cap of $218.96 million, a PE ratio of -3.70 and a beta of 1.42. SeaSpine has a twelve month low of $5.55 and a twelve month high of $20.50.

SeaSpine (NASDAQ:SPNE – Get Rating) last issued its quarterly earnings data on Tuesday, May 3rd. The medical equipment provider reported ($0.45) EPS for the quarter, missing analysts' consensus estimates of ($0.35) by ($0.10). SeaSpine had a negative return on equity of 20.19% and a negative net margin of 29.09%. The company had revenue of $50.69 million for the quarter, compared to analyst estimates of $48.96 million. During the same quarter in the previous year, the business earned ($0.46) earnings per share. The company's revenue was up 20.8% on a year-over-year basis. Equities analysts forecast that SeaSpine will post -1.38 EPS for the current fiscal year.

Insider Buying and Selling at SeaSpine

In other SeaSpine news, insider Beau Standish sold 50,000 shares of SeaSpine stock in a transaction on Thursday, July 14th. The shares were sold at an average price of $5.73, for a total value of $286,500.00. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 9.32% of the company's stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Amalgamated Bank bought a new position in shares of SeaSpine in the 1st quarter valued at about $55,000. Paradigm Capital Management Inc. NY grew its position in shares of SeaSpine by 0.4% in the 1st quarter. Paradigm Capital Management Inc. NY now owns 558,100 shares of the medical equipment provider's stock valued at $6,786,000 after acquiring an additional 2,000 shares during the period. Carlson Capital Management bought a new position in shares of SeaSpine in the 1st quarter valued at about $231,000. Engineers Gate Manager LP bought a new position in shares of SeaSpine in the 1st quarter valued at about $137,000. Finally, Invesco Ltd. grew its position in shares of SeaSpine by 45.4% in the 1st quarter. Invesco Ltd. now owns 30,244 shares of the medical equipment provider's stock valued at $368,000 after acquiring an additional 9,441 shares during the period. Institutional investors own 73.10% of the company's stock.

About SeaSpine

(Get Rating)

SeaSpine Holdings Corporation, a medical technology company, focuses on the design, development, and commercialization of surgical solutions for the treatment of spinal disorders in the United States and internationally. It offers orthobiologics and spinal implant solutions for the neurosurgeons and orthopedic spine surgeons to perform fusion procedures in the lumbar, thoracic, and cervical spine.

See Also

• Get a free copy of the StockNews.com research report on SeaSpine (SPNE)
• MarketBeat: Week in Review 7/11 – 7/15
• Should You Have These Two Banks In Your Portfolio?
• Is Coupang's Stock On The Verge Of A Turnaround?
• Verint Systems Stock is a Customer Engagement Play
• Why Shopify Stock Split...And is as Shoppable as Ever

Receive News & Ratings for SeaSpine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SeaSpine and related companies with MarketBeat.com's FREE daily email newsletter.